231 related articles for article (PubMed ID: 32296499)
1. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.
Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL
Br J Clin Pharmacol; 2023 Mar; 89(3):1162-1175. PubMed ID: 36239542
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
[TBL] [Abstract][Full Text] [Related]
7. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Analysis for Model-Based Therapeutic Drug Monitoring of Tacrolimus in Chinese Han Heart Transplant Patients.
Cheng Y; Chen J; Lin X; Qiu H; Zhang J
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):89-100. PubMed ID: 36482138
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
10. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients.
Chen YS; Liu ZQ; Chen R; Wang L; Huang L; Zhu X; Zhou TY; Lu W; Ma P
Acta Pharmacol Sin; 2017 Aug; 38(8):1195-1204. PubMed ID: 28552913
[TBL] [Abstract][Full Text] [Related]
13. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
[TBL] [Abstract][Full Text] [Related]
15. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
Xue L; Rui JZ; Zhang Y; Miao LY
Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of cyclosporine in chinese cardiac transplant recipients.
Yin OQ; Lau SK; Chow MS
Pharmacotherapy; 2006 Jun; 26(6):790-7. PubMed ID: 16716132
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
[TBL] [Abstract][Full Text] [Related]
18. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
[TBL] [Abstract][Full Text] [Related]
19. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]